Minor
Infant Malaria Vaccine Schedule Optimization
Enrollment closed, study ongoing
PATHPhase 2 NCT06879327 Registry history of NCT06879327 on ClinicalTrials.gov (opens the registry)
Updated
2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.
Enrollment closed, study ongoing
PATHPhase 2 NCT06879327 Registry history of NCT06879327 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Primary completion date changed from estimate of May 15, 2026 to Sep 22, 2026
PATHPhase 2 NCT05644184 Registry history of NCT05644184 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1/2 | 1 | |
| Phase 2 | 3 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06516042 | Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara… | Plasmodium Falciparum | Active, Not Recruiting | 2025-05-06 |
| Phase 2 | ||||
| NCT05654467 | Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama | Poliomyelitis | Recruiting | 2026-05-11 |
| NCT06895486 | Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation | Poliomyelitis | Recruiting | 2026-01-09 |
| NCT06879327 | Infant Malaria Vaccine Schedule Optimization | Malaria Vaccines | Active, Not Recruiting | 2026-09-29 |
| Phase 1/2 | ||||
| NCT06137664 | Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines | Poliomyelitis | Recruiting | 2025-06-03 |
| Not specified | ||||
| NCT06129916 | Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB | Opioid Dependence | Not Yet Recruiting | 2025-10-07 |